Health Products

Access Hstni

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Medical devices - Chemistry
Product: Access Hstni
Issue: Medical devices - Inaccurate test or measurement results
What to do: Contact the manufacturer if you require additional information.
Audience: General public, Health professionals, Hospitals
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Affected ProductsLot or Serial NumberModel or catalog number
Access HstniAll lots.B52699

Issue

FA-000604, which was distributed in August 2021, notified customers of possible intra-assay carryover. The letter communicated that clinically significant carryover into a reagent pack (into-pack) can occur if an Access Hstni test is performed after a sample with a CTNI concentration >270,000 pg/ml (ng/l) and uses the same reagent pipettor. A subsequent investigation has determined that sample-to-sample carryover may also occur under certain conditions confirming that intraassay carryover encompasses into-pack and sample-to-sample carryover. Through these subsequent studies, BEC determined that clinically significant sample-to-sample carryover can occur in Hstni samples that are tested after a sample with a CTNI concentration >55,000 pg/ml (ng/l).

Recall start date: Feb 9, 2022

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime